kabutan

Chordia Therapeutics, Sep-Nov (1Q) Ordinary Profit Loss Widens

Tue Jan 14, 2025 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results at noon (11:30) on January 14th. The ordinary loss (non-consolidated) for the first quarter of the fiscal year ending August 2025 (September to November) expanded to a loss of 615 million yen (compared to a loss of 413 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Sep - Nov, 2024 0 -624 -615 -616 -9.1 ー Jan 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 Guidance ー -2,434 -2,378 -2,380 -34.5 0 Oct 11, 2024 J-GAAP
YoY － -35.1% -30.4% -30.3% -10.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Mar - May, 2024 0 -371 -374 -375 -6.7 -Inf Jul 16, 2024 J-GAAP
Jun - Aug, 2024 0 -621 -649 -650 -11.1 -Inf Oct 11, 2024 J-GAAP
Sep - Nov, 2024 0 -624 -615 -616 -9.1 -Inf Jan 14, 2025 J-GAAP
YoY － － － － －

Related Articles